Patients who are diagnosed with fibromyalgia and CFS, (chronic fatigue syndrome) have always been placed under suspicion. For years they have had to put up with both their symptoms and the possible invention of their illnesses. Conditions which could not be identified through clinical tests. But this has changed thanks to a study which confirms what was already suspected by a part of the medical community: the origin of the two illnesses is found in genetics.
At Genomic Genetics International a specific genomic study has been developed for such alterations which allows us to establish a personalized treatment protocol to improve sufferers’ quality of life and minimalize the negative impact of these illnesses.
Designed specifically for people diagnosed with or suspected of suffering from any type of disease or illness called Idiopathic Environment-Associated Diseases. As is the case of Fibromyalgia, chronic fatigue syndrome (CFS) or multiple sensitivity syndrome.
It is shown to be a useful and effective treatment at any time, although the earlier it starts the greater the degree of improvement achieved. The key is in not only managing the key points of our genes associated with hypersensitivity better, but also before.
- antioxidante defence
- immune system response and pro-inflammatory tendency
- adrenergic system
- B vitamins in methylation pathways
- hormonal metabolism
- neurocognitive and psychoaffective potential
- genetic medicine